Needham & Company Reiterates Jazz Pharmaceuticals (JAZZ) at Buy on Earnings, Analyst Doesn't Expect Stock to Uptick Short-Term, but Highlights Strong Execution and Fundamentals
(Premium-only article. Please sign in or upgrade to SI Premium to view.)